Metformin Protects Neurons against Oxygen-Glucose Deprivation/Reoxygenation -Induced Injury by Down-Regulating MAD2B

Abstract

Background/Aims: Metformin, the common medication for type II diabetes, has protective effects on cerebral ischemia. However, the molecular mechanisms are far from clear. Mitotic arrest deficient 2-like protein 2 (MAD2B), an inhibitor of the anaphase-promoting complex (APC), is widely expressed in hippocampal and cortical neurons and plays an important role in mediating high glucose-induced neurotoxicity. The present study investigated whether metformin modifies the expression of MAD2B and to exert its neuroprotective effects in primary cultured cortical neurons during oxygen-glucose deprivation/reoxygenation (OGD/R), a widely used in vitro model of ischemia/reperfusion. Methods: Primary cortical neurons were cultured, deprived of oxygen-glucose for 1 h, and then recovered with oxygen-glucose for 12 h and 24 h. Cell viability was measured by detecting the levels of lactate dehydrogenase (LDH) in culture medium. The levels of MAD2B, cyclin B and p-histone 3 were measured by Western blot. Results: Cell viability of neurons was reduced under oxygen-glucose deprivation/reoxygenation (OGD/R). The expression of MAD2B was increased under OGD/R. The levels of cyclin B1, which is a substrate of APC, were also increased. Moreover, OGD/R up-regulated the phosphorylation levels of histone 3, which is the induction of aberrant re-entry of post-mitotic neurons. However, pretreatment of neurons with metformin alleviated OGD/R-induced injury. Metformin further decreased the expression of MAD2B, cyclin B1 and phosphorylation levels of histone 3. Conclusion: Metformin exerts its neuroprotective effect through regulating the expression of MAD2B in neurons under OGD/R.

Inhibition of the SOCS1-JAK2-STAT3 Signaling Pathway Confers Neuroprotection in Rats with Ischemic Stroke

“…Ischemic stroke has a high mortality rate and often leads to disability due to the occlusion of the main cerebral artery—this loss of blood flow seriously affects the physical and mental health of individuals who suffer from stroke [4]. The current treatments for ischemic stroke mainly dependent on blood flow restoration using either pharmacological thrombolysis or mechanical thrombectomy, both of which carry side effects that aggravate the injury to the ischemic brain tissue after reperfusion [18]. Therefore, it is urgent to find an effective treatment for patients suffering from ischemic stroke.…”

By Activating Akt/eNOS Bilobalide B Inhibits Autophagy and Promotes Angiogenesis Following Focal Cerebral Ischemia Reperfusion

“…Occlusion of cerebral arteries, such as the middle cerebral artery, causes ischemic stroke. An ischemic stroke leads to a number of neurotoxic events, including oxidative stress, inflammation, and calcium overload, which finally leads to the death of neurons, and other cell types within the brain [2,3]. Although previous studies have identified some neuroprotective agents, such as cinnamophilin, Epigallocatechin gallate (EGCG), and oxyresveratrol, their beneficial effects are still very limited.…”

The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth

“…Metformin may also have a role in cardio‐protection via its effect on the endothelial nitric oxide synthase dependent pathway which can stimulate ischaemia‐induced revascularization. It can also be neuroprotective, reducing neuronal damage by preventing etoposide‐induced apoptosis in neurons .…”